Tamoxifen

Tamoxifen is presently the largest selling breast cancer treatment for early and advanced breast cancer. Known as an "oral selective estrogen receptor modulator," the tamoxifen cancer treatment has been approved by the USDA as a treatment for reducing breast cancer in women who are at a high risk of breast cancer in addition for the reduction of contralateral breast cancer (cancer in the opposite breast). Researching consumer information on tamoxifen is a good idea, due to the latest research being done. On the negative side, most of the Tamoxifen side effects are minor--some of these side effects of tamoxifen are dizziness, nausea, rash, not flashes, headaches, depression, discharges, or bleeding. And sometimes, it can cause a blockage in the lung or brain, along with forming in a vein. It can increase the risk of uterus cancer, cataracts, and other eye problems. But overall, a woman who is diagnosed with high risks of breast cancer need to be sure of the best chance there is of decreasing the breast cancer. To do this, this particular class of medicine acts on the estrogen receptor.

The tamoxifen Zoloft combination does not work well together, as demonstrated by some of the latest research and studies. Scientists and researchers have found that even though tamoxifen was one of the original treatments for breast cancer, women who were later screened by their DNAs, with he studies focusing on the genes of the individual that actually broke-down the tamoxifen once it entered the body, it was found there were many variations of the genes. The later studies were to see which gene variations actually worked on the blood levels of the tamoxifen.

It was found that women with the genetic variation, who took the SSRIs and the newer antidepressants with tamoxifen, could not break down the tamoxifen drug in their body as well as those without the variation. This test result was with blood tests, containing less of the ingredient in the blood called "endoxifen"-- this ingredient is obtained when the body breaks down the drug tamoxifen. And the women who took the SSRIs antidepressants had about 38% lower levels in their blood, compared to those who did not. And different depressants had a stronger or weaker than others, with Effexor had less of an impact on the tamoxifen than did Paxil.

Other areas of information for researching are tamoxifen and calcium supplements, continued tamoxifen therapy, tamoxifen chemical nature, high dose tamoxifen, history of tamoxifen, tamoxifen and breast cancer, or asking the question why take tamoxifen for 5 years, tamoxifen citrate?